Through our blog, we hope to create a community where we can support and challenge each other through conversations, discussions and storytelling, and work together to move the field of oncology forward.

  • Unleashing the Potential of Clinico-Genomic Information: ASCO 2017

    Precision oncology requires a robust understanding of how genomic information relates to clinical outcomes and treatment response. To make this connection, we need to integrate multiple sources of data into single databases that have the power to inform new clinical insights. This has historically been difficult …

    Continue Reading

  • Trials and Outcomes: Accelerating Precision Medicine at ASCO 2017

    At Foundation Medicine, our vision for precision oncology is based on fundamentally changing the way patients receive care. For us, this means enabling practical and clinically applicable solutions, no matter the stage or composition of the cancer, and regardless of where the patient lives or is being …

    Continue Reading

  • Evolving at the Speed of Cancer: FoundationACT® Liquid Biopsy Data at ASCO 2017

    Comprehensive genomic profiling has opened the door to more precise medicines for many patients. Researchers and oncologists can identify genomic drivers of cancer growth or resistance to therapy, often with just a small tissue sample. But even if a tissue biopsy isn’t feasible, such as in patients with advanced …

    Continue Reading

  • At ASCO 2017, Foundation Medicine is presenting new comprehensive genomic profiling data spanning 15 different tumor types. Learn more about the insights FoundationOne® can provide for both targeted therapies and immunotherapies across a range of different cancers. Learn more about our posters and presentations at …

    Continue Reading

  • This week was the American Association for Cancer Research (AACR) annual meeting in Washington, DC. As we followed the event, we identified the 140-character anecdotes and quotes that shine a light on emerging trends in cancer research. Cancer immunotherapy continues to be a hot topic. While the treatment landscape …

    Continue Reading

  • Tissue biopsy isn’t the only path forward. FoundationACT provides comprehensive genomic results using only a blood sample, and can have a profound clinical impact. Learn more about Foundation Medicine’s liquid biopsy test …

    Continue Reading

  • Diving Deeper Into Cancer Immunotherapy Biomarkers

    Cancer immunotherapy is transforming the treatment landscape for many types of cancer, but identifying those people most likely to benefit from these new treatments is one of the biggest hurdles facing the field. Personalized targeted therapies have traditionally been prescribed based on the presence of single …

    Continue Reading

  • Completing the Puzzle for Colorectal Cancer

    Each person and each cancer is unique, and the goal of precision medicine is to uncover this individuality. For colorectal cancer (CRC), we have discovered a few important pieces of the puzzle, but the entire picture is incomplete. There is an urgent need to discover more specific predictive markers of CRC that can …

    Continue Reading

  • A child getting diagnosed with cancer is devastating and can often be compounded by not knowing how to help, or what to do next. Many pediatric cancers are still not well understood, and it remains the leading cause of death by disease among children in the United States.1 Fortunately, advances in research have …

    Continue Reading